Products

RetinaLyze
RetinaLyze System A/S
Ophthalmology AI
RetinaLyze is an AI-powered software for eye care professionals, offering faster, safer screenings for diabetic retinopathy, AMD, and glaucoma using retinal images and OCT scans, with instant AI analysis and built-in telemedicine.

See all 1 product →

About RetinaLyze System A/S

RetinaLyze System A/S is a Denmark-based healthcare AI company specializing in artificial intelligence and telemedicine solutions for the optometry and healthcare industries. Their core offering is an eye-screening software that assists eye care professionals in the early detection of retinal pathologies by automatically analyzing fundus images and Optical Coherence Tomography (OCT) scans. The system delivers instant results, functioning as a clinical decision support system or a screening tool in conjunction with a telemedicine module.

The software is widely utilized in various settings, including hospitals, eye clinics, optical chains, and optometrists’ stores, and has performed over 7 million screenings. RetinaLyze aims to facilitate global access to eye examinations, thereby preventing the adverse effects of untreated retinal conditions by automating routine screening tasks, which enhances the affordability and accessibility of eye care services. The company is also actively involved in research and development to detect new diseases in retinal images, such as Alzheimer’s, using advanced AI algorithms.

For physicians, RetinaLyze provides a fast, intelligent, and effortless screening workflow, integrating with over 60 device and software partners. It offers explainable results with overlays and extracts measurements like cup/disc ratio and disc area. The system supports compliant and efficient operations, reducing manual workload for eye specialists and improving the quality of screening by enabling timely referrals.

Focus Areas

Diabetic Retinopathy (DR) Age-related Macular Degeneration (AMD) Glaucoma AI-driven eye screening telemedicine clinical decision support 3D ONH morphology visualization perimetry analysis

Business Intelligence

TechnologyCloud-based, automated AI analyzing fundus images and OCT scans, telemedicine module, integrations with 60+ device and software partners, 3D ONH morphology visualization, perimetry analysis

What Physicians Need to Know

Diabetic Retinopathy (DR) Screening
AI-powered automated screening and detection of signs of Diabetic Retinopathy from both fundus images and OCT scans, aiding in early intervention.
Age-related Macular Degeneration (AMD) Screening
Automated AI analysis for the detection of signs of Age-related Macular Degeneration using fundus images and OCT scans.
Glaucoma Detection & Progression Tracking
AI-driven screening for glaucoma, including early detection and consistent progression tracking through the Glaucoma Index of Progression (GIP) and 3D ONH morphology visualization from fundus and OCT images.
AI-driven Eye Screening
Utilizes advanced AI and deep learning algorithms for rapid, automated analysis of retinal images (fundus and OCT scans), detecting over 70 signs of pathology with results often in under a minute.
Telemedicine Integration
Features a built-in telemedicine module that facilitates remote consultations with ophthalmologists, enabling expert assessment and validated referrals.
Clinical Decision Support System (CDSS)
Provides instant, easy-to-understand results with Red, Yellow, and Green recommendations, along with explainable overlays and measurements (e.g., cup/disc ratio, disc area) to support clinical decision-making.
3D ONH Morphology Visualization
A unique feature that reconstructs a 3D model of the optic nerve head (ONH) from standard 2D retinal images, offering structural and perfusion-based insights previously accessible only through OCT.
Perimetry Analysis (Inferred)
The Glaucoma module analyzes the color composition of the optic nerve head in fundus images to estimate local hemoglobin distribution, providing insights comparable to visual perimetry and OCT screening methods without requiring additional equipment.
Speed & Efficiency
Delivers analysis results for fundus images in 30-45 seconds and OCT scans in 45 seconds, significantly streamlining clinical workflows and increasing patient throughput.
Clinical Validation & Certifications
All algorithms and services are CE-marked, clinically validated, patented, and the company is ISO-13485 certified, ensuring high standards of diagnostic accuracy and care.
Extensive Real-World Usage
Over 7 million screenings performed in more than 20 countries since 2013, demonstrating proven reliability and widespread adoption in various eye care settings.
Physician Tip

For physicians, RetinaLyze offers a powerful tool to enhance patient care and practice efficiency. Leverage its AI to achieve earlier and more accurate detection of Diabetic Retinopathy, AMD, and Glaucoma, even identifying subtle changes that might otherwise be missed. The rapid analysis (under a minute for most screenings) allows for increased patient throughput and frees up valuable time for complex cases. Utilize the integrated telemedicine feature for expert ophthalmologist consultations and validated referrals, which can significantly reduce false positives and build stronger referral relationships. The unique 3D ONH morphology visualization provides crucial structural and perfusion insights from standard 2D images, a valuable asset especially in clinics without immediate OCT access. Furthermore, the Glaucoma Index of Progression (GIP) enables precise tracking of disease progression over time, facilitating proactive management. The system's explainable AI results with visual overlays and comprehensive, redesigned PDF reports streamline documentation and communication with both colleagues and patients, ensuring consistent, high-quality care regardless of staff experience. By centralizing patient data and images, RetinaLyze simplifies longitudinal comparisons of retinal changes, supporting better long-term patient management.

RetinaLyze is a cloud-based web application compatible with the majority of commercially available fundus and OCT cameras. It can be accessed online via a web browser or seamlessly integrated into existing healthcare center software systems. The platform supports integration with PACS/EHR for efficient digital referrals, and the RetinaLyze OCT module is also available via API for custom integrations.

Products by RetinaLyze System A/S

1 product in the directory

RetinaLyze
RetinaLyze System A/S
Ophthalmology AI
RetinaLyze is an AI-powered software for eye care professionals, offering faster, safer screenings for diabetic retinopathy, AMD, and glaucoma using retinal images and OCT scans, with instant AI analysis and built-in telemedicine.

What the Web Says

RetinaLyze System A/S, known for its RetCAD and RetAlyze products, generally receives positive feedback for its innovative AI-powered retinal image analysis tools, particularly for ophthalmologists and optometrists. Users appreciate its efficiency in detecting and managing eye diseases. Employer reviews are less prevalent but suggest a positive work environment.

Overall: Positive

Strengths

  • AI-powered analysis for efficient disease detection (e.g., AMD, DR)
  • Enhances diagnostic accuracy for ophthalmologists and optometrists
  • Streamlines workflow in eye care practices
  • User-friendly interface for medical professionals
  • Potential for early intervention and improved patient outcomes
  • Positive impact on clinical decision-making

Limitations

  • Limited public reviews on major platforms like G2, Capterra, Glassdoor
  • Specific pricing information not readily available
  • Potential learning curve for new users integrating into existing systems
  • Reliance on internet connectivity for cloud-based features
  • Specific technical support experiences are not widely documented
  • No significant negative product or employer reviews found

Based on reviews from: RetinaLyze.com (product information), Healthcare IT news articles and industry reviews, Ophthalmology and optometry professional forums (limited mentions), LinkedIn (company information, employee profiles)

Last updated: 2026-08-12

Videos

News, demos, and interviews about RetinaLyze System A/S.

Loading videos...

Videos load interactively. If none appear, search YouTube for RetinaLyze System A/S →

View all on YouTube

Press & Coverage

Optometry Times
RetinaLyze System A/S unveils AI to aid in the early detection of glaucoma
RetinaLyze System A/S has introduced an advanced AI, the Glaucoma Index of Progression (GIP), designed for stable and consistent tracking of glaucoma progression. This AI aims to detect glaucoma early by measuring subtle changes and comparing both eyes simultaneously.
2024-10
RetinaLyze.com
RetinaLyze and Medicontur CZ Announce Strategic Distribution Partnership in the Czech Republic
RetinaLyze System A/S has partnered with Medicontur CZ s.r.o. to distribute its AI and telemedicine solutions for optometry and healthcare in the Czech Republic. This collaboration aims to expand the reach of RetinaLyze's advanced eye care technology.
2024-12
RetinaLyze.com
RetinaLyze partners with FE-Group srl to strengthen AI-powered eye screening in Italy
RetinaLyze System A/S has announced a strategic partnership with FE-Group srl in Italy to enhance AI-powered eye screening. This collaboration will bring RetinaLyze's CE-certified AI screening software to eye-care professionals across Italy.
2025-11
RetinaLyze.com
RetinaLyze and EyeVinci Announce Strategic Distribution Partnership in the Dutch Market
RetinaLyze System A/S has formed a strategic partnership with Eyevinci B.V. to bring advanced AI-powered eye screening solutions to the Dutch market. This aims to improve eye health outcomes through faster and more accurate detection of conditions like diabetic retinopathy, AMD, and glaucoma.
2025-09
RetinaLyze.com
RetinaLyze Year in Review 2025: A Year of Strong Science, New Integrations & Global Momentum
The 2025 year in review highlights RetinaLyze's advancements in science, clinical tools, integrations, and global access to eye screening. New research challenged assumptions about glaucoma, and a study showed AI-assisted diabetic retinopathy screening in general practice successfully reached patients who typically miss standard screening.
2025-12
RetinaLyze.com
RetinaLyze launches redesigned clinical PDF report u2013 clearer communication for colleagues and patients
RetinaLyze is introducing a new, streamlined PDF report for customers starting January 15, 2026. This redesign aims to improve communication of results to colleagues, referrers, and patients with a clearer, more modern layout.
2026-01
PMC (PubMed Central)
A scoping review of artificial intelligence as a medical device for ophthalmic image analysis in Europe, Australia and America
A scoping review published in May 2025 examined AI as a medical device for ophthalmic image analysis, noting RetinaLyze System A/S as a CE Class I device approved in Denmark for detecting DR, AMD, and glaucoma using fundus photographs. The review highlights the regulatory landscape and challenges in evaluating AIaMDs.
2025-05
RetinaLyze.com
RetinaLyze and OCULUS spol. s r.o. announce strategic cooperation to expand AI-powered eye screening across the Czechia
RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, announced a strategic cooperation with OCULUS spol. s r.o. to expand AI-powered eye screening across Czechia.
2026-04

Frequently Asked Questions

RetinaLyze's AI-powered software is designed for the early detection of signs of Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma. It analyzes both standard fundus images and Optical Coherence Tomography (OCT) scans to identify potential pathologies.
RetinaLyze provides instant AI analysis of images, delivering results in as little as 30-45 seconds, which serves as a clinical decision support system. It also features a built-in telemedicine module, allowing for communication with ophthalmologists for manual assessments and facilitating digital referrals to specialists.
For glaucoma, RetinaLyze offers 3D Optic Nerve Head (ONH) morphology visualization reconstructed from standard 2D retinal images, providing structural and perfusion-based insights previously requiring OCT. Additionally, it includes a Glaucoma Index of Progression (GIP) to track subtle changes over time, though its primary focus is on image analysis rather than perimetry.
RetinaLyze's AI screening software is CE-certified and its quality management system is ISO 13485:2016 certified. The company also ensures compliance with data protection regulations like GDPR in Europe and is aware of the new European AI Act.
RetinaLyze operates on a subscription-based model, with costs varying depending on the number of screenings performed, averaging around £0.35 to £1.73 per patient for fundus and OCT analysis. They offer customer support via email and phone, along with a helpdesk and local support through their distribution partners.
Established in 2013, RetinaLyze has performed over 7 million screenings across more than 20 countries, demonstrating a strong operational track record. They have secured funding from entities like The European Regional Development Fund and maintain strategic distribution partnerships across Europe, including Italy, the Netherlands, Slovakia, and the Czech Republic.
RetinaLyze's algorithms are clinically validated and provide results that are on par with manual gradings, designed to assist healthcare professionals rather than provide a definitive diagnosis. The system combines AI efficiency with the option for ophthalmologist backup via telemedicine, ensuring a robust and reliable screening process.

Related Companies

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Xealth is a healthcare AI company that provides a care orchestration platform designed to seamlessly integrate digital health tools and programs into existing clinical workflows. For physicians, this means the ability to prescribe and monitor digital health content, applications, and services directly from within their Electronic Health Record (EHR) system, much like ordering traditional medications. […]

CureCompanion is a healthcare technology company that specializes in virtual care solutions, offering an integrated platform of hardware and software for telemedicine. Their technology goes beyond basic video conferencing, enabling healthcare providers to conduct comprehensive virtual examinations. This includes the ability to examine skin, eyes, ears, and throat using HD cameras, listen to heart and […]

Teladoc Health is a multinational telemedicine and virtual healthcare company that offers a comprehensive suite of services designed to connect patients with licensed medical professionals through technology-enabled platforms. For physicians, Teladoc Health provides tools and insights to deliver high-quality care across various specialties, from general medical to complex chronic condition management. The company’s offerings include […]

Headspace Health is a prominent digital mental health company that offers a comprehensive suite of mental well-being solutions. For physicians, Headspace Health provides end-to-end mental healthcare designed to address the unique challenges faced by healthcare professionals, such as burnout, stress, and the emotional toll of frontline care. The platform offers 24/7 on-demand behavioral coaching, guided […]

August AI is a healthcare artificial intelligence company that has developed an AI-powered digital health companion. This platform is designed to provide accessible medical care and health guidance, acting as a ‘health companion’ rather than a replacement for clinical visits. It assists users in understanding symptoms, interpreting medical reports, and managing ongoing treatment. The company’s […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.